Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 30, 2013
Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCADRadoslav Chekerov, Ioana Braicu, Dan Cacsire Castillo-Tong, et al.
Plos One|December 16, 2017
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriersDaphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, et al.
Plos One|April 18, 2018
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriersDaphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 8, 2011
Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literatureGerda Hofstetter, Astrid Berger, Martina Chamson, et al.
Gynecologic Oncology|October 5, 2014
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancerEvelyn Despierre, Matthieu Moisse, Betül Yesilyurt, et al.
Cancer|October 26, 2012
Methylation status of TUSC3 is a prognostic factor in ovarian cancerDietmar Pils, Peter Horak, Petr Vanhara, et al.
Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.
Cancer Science|April 14, 2012
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD ConsortiumDietmar Pils, Gudrun Hager, Dan Tong, et al.
Cancers|January 11, 2022
Prognostic Significance of <i>SLFN11</i> Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian CancerVictoria Tserpeli, Dimitra Stergiopoulou, Dora Londra, et al.
Carcinogenesis|October 6, 2019
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional studyKonstantina Panoutsopoulou, Margaritis Avgeris, Konstantinos Mavridis, et al.
Pageof 19